-
Histological Outcomes And Jak-Stat Signalling In Ulcerative Colitis Patients Treated With Tofacitinib
van Gennep, S., Fung, I. C. N., de Jong, D. C., Ramkisoen, R. K., Clasquin, E., de Jong, J., de Vries, L. C. S., de Jonge, W. J., Gecse, K. B., Löwenberg, M., Woolcott, J. C., Mookhoek, A. & D'Haens, G. R., 1 Aug 2024, In: Journal of Crohn's & Colitis. 18, 8, p. 1283-1291 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis
de Vries, L. C. S., Ghiboub, M., van Hamersveld, P. H. P., Welting, O., Verseijden, C., Bell, M. J., Rioja, I., Prinjha, R. K., Koelink, P. J., Strobl, B., Müller, M., D'Haens, G. R., Wildenberg, M. E. & de Jonge, W. J., 6 Apr 2021, In: Journal of Crohn's & Colitis. 15, 4, p. 617-630 14 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Janus kinase inhibition in the treatment of inflammatory bowel disease
de Vries, L. C. S., 2020, 170 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
- All publications